Clinical Response to Upfront Targeted Tyrosine Kinase Inhibitors among Patients with Myeloid/Lymphoid Neoplasms with Eosinophilia and Tyrosine Kinase Gene Fusion.
暂无分享，去创建一个
L. Moscinski | E. Padron | B. Shah | Ling Zhang | Endi Wang | L. Sokol | O. Chan | D. Sallman | R. Komrokji | J. Lancet | S. Ball | Seongseok Yun | A. Kuykendall | Chuanyi M. Lu | N. Dong | Yumeng Zhang | M. Lauw | T. Knepper | L. Nguyen